Supplementary Figure 1 from Distinguishing Clinicopathologic Features of Patients with V600E and V600K <i>BRAF</i>-Mutant Metastatic Melanoma — Alexander M. Menzies (2023) | RDL Network
Supplementary Figure 1 from Distinguishing Clinicopathologic Features of Patients with V600E and V600K <i>BRAF</i>-Mutant Metastatic Melanoma
Preprint 2023 en
Authors
AM
Alexander M. Menzies
LH
Lauren E. Haydu
LV
Lydia Visintin
Abstract
1 min read
<p>PDF file, 53KB, A survival curve of all patients as outlined on page 23 of the paper:Supplementary Figure S1. Overall survival from distant metastasis based on BRAF and inhibitor status for all patients (n=308).</p>
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.